Position in REGN
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$17,253,975
+$8,866,196 QoQ
Shares Held
27,671
+154.9% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
#230
of 1,322 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kimelman & Baird, LLC holds $17,254,882 across 2 Biotechnology names. REGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
27,671 | $17,253,975 | |
| 2 | NKTR |
Nektar Therapeutics
|
13 | $907 |
All Filings in REGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,253,975 | 27,671 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $8,387,779 | 10,856 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $242,367 | 314 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $30,362 | 54 | Shares | Sole | 2025-11-25 | |
| 2025-06-30 | $28,350 | 54 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $34,248 | 54 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $38,465 | 54 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $56,766 | 54 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $56,755 | 54 | Shares | Sole | 2024-08-19 | |
| No filing history on record for this holder in this stock. | ||||||